Merkel Cell Carcinoma Metastases To Caruncle With Orbital Extension: Report and Literature Review.
Journal
Ophthalmic plastic and reconstructive surgery
ISSN: 1537-2677
Titre abrégé: Ophthalmic Plast Reconstr Surg
Pays: United States
ID NLM: 8508431
Informations de publication
Date de publication:
29 Apr 2024
29 Apr 2024
Historique:
medline:
30
4
2024
pubmed:
30
4
2024
entrez:
30
4
2024
Statut:
aheadofprint
Résumé
Merkel cell carcinoma (MCC) is an uncommon and aggressive skin cancer of neuroendocrine origin. The tumor usually presents with a locoregional spread and most frequently metastasizes to the skin, liver, bone, lung, and brain. Despite the orbit being a relatively common site of metastases, it has rarely been reported in patients with MCC. The authors present a case of biopsy-proven orbital metastatic MCC in an 86-year-old male who presented with a rapidly enlarging right caruncle/subconjunctival mass with orbital extension and a history of forearm MCC excision 3 years prior. There are only 3 reported cases of distant metastatic MCC to the orbit, all presenting as a mass originating from extraocular muscles; and no cases of caruncle involvement.
Identifiants
pubmed: 38687345
doi: 10.1097/IOP.0000000000002697
pii: 00002341-990000000-00383
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 The American Society of Ophthalmic Plastic and Reconstructive Surgery, Inc.
Déclaration de conflit d'intérêts
The authors have no financial or conflicts of interest to disclose.
Références
Peters GB, Meyer DR, Shields JA, et al. Management and prognosis of Merkel cell carcinoma of the eyelid. Ophthalmology 2001;108:1575–1579.
Kivelä T, Tarkkanen A. The Merkel cell and associated neoplasms in the eyelids and periocular region. Surv Ophthalmol 1990;35:171–187.
Wijaya WA, Liu Y, Qing Y, et al. Prevalence of Merkel cell polyomavirus in normal and lesional skin: a systematic review and meta-analysis. Front Oncol 2022;12:868781.
Spassova I, Ugurel S, Kubat L, et al. Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma. J ImmunoTher Cancer 2022;10:1–12.
Lemos BD, Storer BE, Iyer JG, et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 2010;63:751–761.
Gauci ML, Aristei C, Becker JC, et al.; European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC). Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline – update 2022. Eur J Cancer 2022;171:203–231.
Goedert JJ. Merkel cell carcinoma: recent progress and current priorities on etiology, pathogenesis, and clinical management. J Clin Oncol 2009;27:4021–4026.
Sims JR, Grotz TE, Pockaj BA, et al. Sentinel lymph node biopsy in Merkel cell carcinoma: the Mayo Clinic experience of 150 patients. Surg Oncol 2018;27:11–17.
Garbutcheon-Singh KB, Curchin DJ, McCormack CJ, et al. Trends in the incidence of Merkel cell carcinoma in Victoria, Australia, between 1986 and 2016. Australas J Dermatol 2020;61:e34–e38.
Song Y, Azari FS, Tang R, et al. Patterns of metastasis in Merkel cell carcinoma. Ann Surg Oncol 2021;28:519–529.
Cugley DR, Roberts-Thomson SJ, McNab AA, et al. Biopsy-proven metastatic Merkel cell carcinoma to the orbit: case report and review of literature. Ophthalmic Plast Reconstr Surg 2018;34:e86–e88.
Johnson D, Warder D, Plourde ME, et al. Orbital metastasis secondary to Merkel cell carcinoma: case report and literature review. Orbit 2013;32:263–265.
Wagner WD, Lahm DW, Dave A, et al. Metastatic Merkel cell carcinoma presenting as an orbital mass. Orbit 2022:1–4.
Kase S, Ishijima K, Ishida S, et al. Merkel cell carcinoma of the conjunctiva. Ophthalmology 2010;117:637.e1–637.e2.
Harms KL, Healy MA, Nghiem P, et al. Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system. Ann Surg Oncol 2016;23:3564–3571.
Bajetta E, Celio L, Platania M, et al. Single-institution series of early-stage Merkel cell carcinoma: long-term outcomes in 95 patients managed with surgery alone. Ann Surg Oncol 2009;16:2985–2993.
Gupta SG, Wang LC, Peñ As PF, et al. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 2006;142:685–690.
Furdová A, Michalková M, Javorská L. Merkel cell carcinoma of the eyelid and orbit. Cesk Slov Oftalmol 2018;74:37–43.
Seiberth V, Woldt C. Merkel cell carcinoma of the eyebrow extending into the orbit. Eur J Ophthalmol 2000;10:330–331.
Yldrm S, Aköz T, Yavuzer D, et al. A case of Merkel cell carcinoma with extension into the orbital cavity. Ann Plast Surg 2001;46:198–199.
Leung VC, Antonios R, Désy D, et al. A case of complete spontaneous regression of extensive Merkel cell carcinoma involving the orbit. Can J Ophthalmol 2021;56:e13–e15.
Voog E, Biron P, Martin JP, et al. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer 1999;85:2589–2595.
Santos-Juanes J, Fernández-Vega I, Fuentes N, et al. Merkel cell carcinoma and Merkel cell polyomavirus: a systematic review and meta-analysis. Br J Dermatol 2015;173:42–49.
Nghiem PT, Bhatia S, Lipson EJ, et al. PD-1 blockade with pembrolizumab in advanced Merkel-cell carcinoma. N Engl J Med 2016;374:2542–2552.
D’Angelo SP, Russell J, Lebbé C, et al. Efficacy and safety of first-line avelumab treatment in patients with stage IV metastatic Merkel cell carcinoma a preplanned interim analysis of a clinical trial. JAMA Oncol 2018;4:E1–E5.
Kaufman HL, Russell J, Hamid O, et al. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. Lancet Oncol 2016;17:1374–1385.
El-Khoueiry AB, Sangro B, Yau T, et al. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial. Lancet 2017;389:2492–2502.
Zaggana E, Konstantinou MP, Krasagakis GH, et al. Merkel cell carcinoma—update on diagnosis, management and future perspectives. Cancers (Basel) 2023;15:1–20.